KNG1 and central nervous system cancer: Bradykinin can stimulate the B2 receptor [21, 22] and epidermal growth factor receptor (EGFR) signaling pathways to enhance the gliomas invasion [23, 24], and then to promote angiogenesis through the increased VEGF expression.